Home / Compare / Ibogaine Treatment MX vs Texas ibogaine trials (IMPACT consortium)

Ibogaine Treatment MX vs Texas ibogaine trials (IMPACT consortium)

Ibogaine Treatment MX and Texas ibogaine trials (IMPACT consortium) side by side: setting, medical team, screening, what is given, length of stay, aftercare, published price and public record. See also the questions to ask.

	Ibogaine Treatment MX	Texas ibogaine trials (IMPACT consortium) Status unconfirmedClinical trial
Category	Licensed medical facility with hospital transfer agreement	State-funded clinical trial program, not enrolling as of October 2026
Location	Mexico City, Mexico	Houston and Galveston, United States
Setting	"Licensed medical facility", explicitly "not a villa", with a private hospital 9 minutes away under a written transfer agreement.	Academic hospitals, under an FDA-supervised protocol, once the trial exists.
Medical team	A cardiologist medical director who reads the 12-lead EKGs and attends dosing; an ACLS emergency physician as the responsible physician; a psychiatrist; an ACLS nurse 24/7; continuous ECG and pulse oximetry, crash cart and oxygen. Physician names and licence numbers are given only in the screening pack.	University physicians and researchers.
Screening before treatment	Potassium, magnesium and liver labs before travel; a physician-planned washout; Suboxone, methadone and SSRI tapers scheduled with the patient's prescriber; no dosing until long-acting opioids have cleared.	Trial eligibility criteria, not yet published.
What is given	Not stated.	To be set by the FDA-approved protocol.
Who it is for	Opioids (heroin, fentanyl, oxycodone; Suboxone and methadone transition), alcohol, stimulants.	Addiction, TBI and other behavioural conditions (the IMPACT consortium: Ibogaine Medicine for PTSD, Addiction and Cognitive Trauma).
Protocol and length of stay	7 days on site, then follow-up to day 90.	A two-year multicentre trial is planned. As of October 2026 no federally authorised ibogaine trial exists in the United States (ARPA-H).
After the treatment	Weekly calls to day 30, then days 45, 60 and 90; a written summary for the home doctor; a US clinician referral list.	Per protocol.
Published price	$12,500 all-inclusive; flights, extra tests and extra nights excluded. The deposit is refunded if the patient is screened out.	No fee expected for trial participants.
Licences and accreditations stated	"COFEPRIS-licensed medical facility" claimed; the number is not published.	Texas SB 2308, signed June 2025, appropriated $50 million; HHSC selected UTHealth Houston and UTMB on December 12, 2025.
Founded / history	Founded 2026 (site); founder Michael Vale.	The statute bars disbursement until non-state matching funds arrive. In March 2026 HHSC said no drug-company proposal met the match requirements; state leaders said Texas would fully fund the program. As of October 8, 2026 no executed contract or disbursement had been confirmed.
Rating (as shown on the cited page)	Not shown on the pages we checked	Not shown on the pages we checked
Public record	None found.	None found.
Status	Operating. Site copyright 2026, updated October 2026. No phone number; the contact email is on an agency domain.	Status unconfirmed. Not enrolling. Anyone searching for ibogaine in Texas today cannot get it through this program yet.

From each program's website and the sources on its profile, checked 2026-10-20.

Compare other programs